Cimino M, Gonçalves R M, Barrias C C, Martins M C L
I3S, Instituto de Investigação e Inovação em Saúde, Universidade do Porto (UP), Porto, Portugal.
Instituto de Engenharia Biomédica (INEB), Universidade do Porto (UP), Porto, Portugal.
Stem Cells Int. 2017;2017:6597815. doi: 10.1155/2017/6597815. Epub 2017 Oct 11.
Human mesenchymal stem/stromal cells (hMSCs) have generated great interest in regenerative medicine mainly due to their multidifferentiation potential and immunomodulatory role. Although hMSC can be obtained from different tissues, the number of available cells is always low for clinical applications, thus requiring expansion. Most of the current protocols for hMSC expansion make use of fetal bovine serum (FBS) as a nutrient-rich supplement. However, regulatory guidelines encourage novel xeno-free alternatives to define safer and standardized protocols for hMSC expansion that preserve their intrinsic therapeutic potential. Since hMSCs are adherent cells, the attachment surface and cell-adhesive components also play a crucial role on their successful expansion. This review focuses on the advantages/disadvantages of FBS-free media and surfaces/coatings that avoid the use of animal serum, overcoming ethical issues and improving the expansion of hMSC for clinical applications in a safe and reproducible way.
人间充质干/基质细胞(hMSCs)因其多向分化潜能和免疫调节作用而在再生医学领域引起了广泛关注。尽管hMSC可从不同组织中获取,但用于临床应用的可用细胞数量始终较少,因此需要进行扩增。目前大多数hMSC扩增方案都使用胎牛血清(FBS)作为营养丰富的补充剂。然而,监管指南鼓励采用新型无血清替代品,以制定更安全、标准化的hMSC扩增方案,同时保留其内在治疗潜力。由于hMSC是贴壁细胞,附着表面和细胞粘附成分对其成功扩增也起着关键作用。本综述重点关注无FBS培养基以及避免使用动物血清的表面/涂层的优缺点,以安全、可重复的方式克服伦理问题并改善hMSC用于临床应用的扩增效果。